The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical efficacy and safety of front-line CDK4/6 inhibitor therapy in HR+/HER2- advanced breast cancer patients with visceral metastases: A retrospective study.
 
Qi Zhao
No Relationships to Disclose
 
Mingxia Jiang
No Relationships to Disclose
 
Jiaxuan Liu
No Relationships to Disclose
 
Mengqi Zhang
No Relationships to Disclose
 
Maiyue He
No Relationships to Disclose
 
Shihan Zhou
No Relationships to Disclose
 
Nilupai Abudureheiyimu
No Relationships to Disclose
 
Xiuwen Guan
No Relationships to Disclose
 
Wenna Wang
No Relationships to Disclose
 
Peng Yuan
No Relationships to Disclose
 
Pin Zhang
No Relationships to Disclose
 
Fei Ma
No Relationships to Disclose
 
Qiao Li
No Relationships to Disclose
 
Binghe Xu
Consulting or Advisory Role - AstraZeneca; Novartis